Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeff Zablocki

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Expert Opinion on Investigational Drugs|November 18, 2008
A1 adenosine receptor agonists and their potential therapeutic applicationsElfatih Elzein, Jeff Zablocki
Purinergic Signalling|June 24, 2008
Progress in the discovery of selective, high affinity A(2B) adenosine receptor antagonists as clinical candidatesRao V Kalla, Jeff Zablocki
Journal of Medicinal Chemistry|September 5, 2013
The drug annotations seriesJeff Zablocki, Carlos Garcia-Echeverria
Purinergic Signalling|July 8, 2008
Preface: special issue on medicinal chemistry of purinesKenneth A Jacobson, Jeff Zablocki, Shripad Bhagwat
Handbook of Experimental Pharmacology|July 30, 2009
A1 adenosine receptor antagonists, agonists, and allosteric enhancersWilliam F Kiesman, Elfatih Elzein, Jeff Zablocki
Handbook of Experimental Pharmacology|July 30, 2009
Recent developments in A2B adenosine receptor ligandsRao V Kalla, Jeff Zablocki, Mojgan Aghazadeh Tabrizi, et al.
Journal of Medicinal Chemistry|September 3, 2004
2-Pyrazolyl-N(6)-substituted adenosine derivatives as high affinity and selective adenosine A(3) receptor agonistsElfatih Elzein, Venkata Palle, Yuzhi Wu, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2008
Selective, high affinity A(2B) adenosine receptor antagonists: N-1 monosubstituted 8-(pyrazol-4-yl)xanthinesRao V Kalla, Elfatih Elzein, Thao Perry, et al.
Journal of Medicinal Chemistry|March 7, 2008
Discovery of a novel A2B adenosine receptor antagonist as a clinical candidate for chronic inflammatory airway diseasesElfatih Elzein, Rao V Kalla, Xiaofen Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2012
Marked difference in saxitoxin and tetrodotoxin affinity for the human nociceptive voltage-gated sodium channel (Nav1.7) [corrected]James R Walker, Paul A Novick, William H Parsons, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Expert Opinion on Investigational Drugs|November 18, 2008
A1 adenosine receptor agonists and their potential therapeutic applicationsElfatih Elzein, Jeff Zablocki
Purinergic Signalling|June 24, 2008
Progress in the discovery of selective, high affinity A(2B) adenosine receptor antagonists as clinical candidatesRao V Kalla, Jeff Zablocki
Journal of Medicinal Chemistry|September 5, 2013
The drug annotations seriesJeff Zablocki, Carlos Garcia-Echeverria
Purinergic Signalling|July 8, 2008
Preface: special issue on medicinal chemistry of purinesKenneth A Jacobson, Jeff Zablocki, Shripad Bhagwat
Handbook of Experimental Pharmacology|July 30, 2009
A1 adenosine receptor antagonists, agonists, and allosteric enhancersWilliam F Kiesman, Elfatih Elzein, Jeff Zablocki
Handbook of Experimental Pharmacology|July 30, 2009
Recent developments in A2B adenosine receptor ligandsRao V Kalla, Jeff Zablocki, Mojgan Aghazadeh Tabrizi, et al.
Journal of Medicinal Chemistry|September 3, 2004
2-Pyrazolyl-N(6)-substituted adenosine derivatives as high affinity and selective adenosine A(3) receptor agonistsElfatih Elzein, Venkata Palle, Yuzhi Wu, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2008
Selective, high affinity A(2B) adenosine receptor antagonists: N-1 monosubstituted 8-(pyrazol-4-yl)xanthinesRao V Kalla, Elfatih Elzein, Thao Perry, et al.
Journal of Medicinal Chemistry|March 7, 2008
Discovery of a novel A2B adenosine receptor antagonist as a clinical candidate for chronic inflammatory airway diseasesElfatih Elzein, Rao V Kalla, Xiaofen Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2012
Marked difference in saxitoxin and tetrodotoxin affinity for the human nociceptive voltage-gated sodium channel (Nav1.7) [corrected]James R Walker, Paul A Novick, William H Parsons, et al.
Pageof 3